SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001165527-18-000225
Filing Date
2018-11-14
Accepted
2018-11-14 15:31:09
Documents
50
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 g8638.htm 10-Q 577966
2 ex31.htm EX-31 13600
3 ex32.htm EX-32 4867
  Complete submission text file 0001165527-18-000225.txt   2755541

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT clcs-20180930.xml EX-101.INS 488446
5 XBRL TAXONOMY EXTENSION SCHEMA clcs-20180930.xsd EX-101.SCH 38633
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcs-20180930_cal.xml EX-101.CAL 40965
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcs-20180930_def.xml EX-101.DEF 123760
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcs-20180930_lab.xml EX-101.LAB 190376
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcs-20180930_pre.xml EX-101.PRE 176711
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 181183187
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1